Rhumatologie

THU0370 CLUSTER-RANDOMIZED PRAGMATIC CLINICAL TRIAL EVALUATING THE POTENTIAL BENEFIT OF A TIGHT-CONTROL AND TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: THE RESULTS OF THE TICOSPA TRIAL

A. Moltó1,C. López-Medina1,F. Van den Bosch1,A. Boonen1,C. Webers1,E. Dernis1F. A. Van Gaalen1,M. Soubrier1,P. Claudepierre1,A. Baillet1,M. Starmans-Kool1,D. Van der Heijde1,M. Dougados1


  1. TICOSPA Study Group, Paris, France

Abstract

Background: Current recommendations for axial spondyloarthritis (axSpA) management include tight control and treat-to-target (TC) strategies, but no study has evaluated its potential benefit

Objectives: To evaluate the benefit of TC strategies in comparison to usual care (UC) in patients with axSpA.

https://ard.bmj.com/content/79/Suppl_1/417.1

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France
Rhumatologie

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France

Treat to target in axial spondyloarthritis: From its concept to its implementation
Rhumatologie

Treat to target in axial spondyloarthritis: From its concept to its implementation

Cost utility modeling of early vs late total knee replacement in osteoarthritis patients.
Rhumatologie

Cost utility modeling of early vs late total knee replacement in osteoarthritis patients.